Abstract-The characteristics of cholecystokinin (CCK) receptors in rat pancreatic acini and in various regions of the brain were examined using synthetic CCK-8 or CCK-7 analogues. 3H-propionylated CCK-8 ([3H] This order of potencies of CCK analogues was greatly different from that in the cerebral cortex.
Abstract-The characteristics of cholecystokinin (CCK) receptors in rat pancreatic acini and in various regions of the brain were examined using synthetic CCK-8 or CCK-7 analogues. 3H-propionylated CCK-8 ([3H]CCK-8) was used as a ligand. This order of potencies of CCK analogues was greatly different from that in the cerebral cortex.
3) The carboxy-terminal tetra-peptide (CCK-4) and penta-peptide (CCK-5) had very weak potencies in displacing [3H]CCK-8 binding in the pancreatic acini, which were 20 to 30-fold less than their potencies in the cerebral cortex. These results suggest that the recognition sites for CCK analogues in the pancreatic and brain CCK receptors are different. Cholecystokinin (CCK) is a peptide hor mone that was first isolated from the porcine intestine as a polypeptide of 33-amino acid residues (CCK-33) (1) . The carboxy-terminal octapeptide (CCK-8) has been found in the intestine (2) and brain (3) . CCK-8 has re cently been considered as a putative neuro transmitter or neuromodulator and may modulate the neuronal activity of catechol aminergic neurons in the mesolimbic system (4-7).
Recently, some research groups have synthesized a number of C-terminal fragments and analogues of CCK-8 to define the speci ficity of the CCK receptor in the exocrine pancreas, gall bladder and brain (8-10 activity with very low potency of gall bladder contracting (CCK) activity (11). These results suggested that at least two recognition sites specific for PZ activity and for CCK activity may be localized in the molecule.
In the present study, we compared the characteristics of the CCK receptors in rat pancreatic acini and various regions of the brain using these CCK-8 analogues and 3H propionylated CCK-8.
Materials and Methods
Animals: Male Wistar rats (180-220 g) from Shizuoka Animal Laboratory (Shizuoka, Japan) were housed in a room at 20-25°C with a 12 hr light-dark cycle (light on 6:00 a.m.) and given free access to commercial food (CE-2, Clea Ltd., Japan) and tap water.
Preparation of pancreatic acini mem branes: Pancreatic acini were isolated by the method of Williams et al. (12, 13) . Briefly, rats were decapitated, and the pancreas was promptly removed from each rat. Then 5 ml of digestion medium [Eagle's MEM containing 0.025% collagenase and 0.025% trypsin inhib itor (FOY-007)] was injected into the paren chyma of the pancreas, and the pancreas was shaken at 120 cycles/min for 10 min at 37'C under 5% CO2 in 02. The digestion medium was replaced by 5 ml of fresh medium and in cubation was continued for 40 min under the same conditions. Pancreatic acini were dis sociated by up and down pipetting in poly propylene pipettes and then filtered through 150 am nylon mesh. The pancreatic acini were purified by centrifugation at 50 x g for 10 min through a stepwise gradient of Eagle's MEM containing 1-4% BSA. The purified pancreatic acini were homogenized in 10 vol. of ice-cold 50 mM Tris-HCI buffer (pH 7.4) containing 5 mM MgC12 with a teflon-glass homogenizer at 4°C. This homogenate was centrifuged at 50,000 x g for 20 min at 4'C. The pellet was resuspended in the same volume of ice-cold 50 mM Tris-HCI buffer containing 5 mM MgC12, and recentrifuged twice for 20 min periods at 50,000xg. The final pellet was frozen at -80°C until use in the binding assays.
Preparation of membranes from various regions of the brain: Rats were decapitated and their brains were rapidly removed. bound in the presence and absence of 1 uM unlabelled CCK-8. The incubation was terminated by adding 2 ml of ice-cold 50 mM Tris-HCI buffer (pH 7.4) con taining 5 mM MgCl2 and 0.2% BSA and then rapid filtration of the mixture on a Whatman glass filter (GF/B). The filter was washed three times with 3 ml of ice-cold same buffer and then permeated with Aquazol-2 for a few hours at room temperature, and radioactivity was counted by a liquid scintillation counter (LSC-900, Aloka).
Protein assay: Protein was measured by the method of Lowry et al. (14) .
Materials: CCK-8 and its analogues were synthesized by Prof. Yanaihara with solution methodology (Table 1) . Purity of the peptides was assessed by amino acid analysis of acid hydrolysates and amino-peptidase M diges tions and by analytical high performance liquid chromatography.
The peptides were found to be sufficiently pure for use. The chymotrypsin inhibitor Antagosan was a gift from Hoechst (W. Germany). The trypsin inhibitor FOY-007 was a gift from Ono Fig. 1 B and D) . Similar plots for binding of [3H]CCK-8 to membranes of other regions of the brain were also linear (data not shown). These results suggest that in which the -OSO3H group associated with tyrosine was replaced by an -NHSO3H group, had a poten cy similar to that of NS-CCK-8 in displacing [3H]CCK-8 specific binding in the pancreatic acini (Fig. 3A) .
On the other hand, in the cerebral cortex, NS-CCK-8
and Suc[Phe(NHSO3H]CCK-7 had about one-tenth and half the potency of CCK-8, respectively (Fig. 3B) . The IC50 values of these analogues for displacing [3H] CCK-8 specific binding are shown in Table 3 (No. 1, 5, 7, 8). These results suggest that the -OSO3H group associated with the tyrosine residue in CCK-8 is important for the binding of CCK-8 to its receptors in the pancreatic acini.
3 Table 3 . Most of the CCK-8 analogues examined had a Hill slope close to unity in displacement experiments.
[D-Ala3]CCK-7 with a substituted glycine selectively stimulated pancreatic exocrine secretion in anesthetized rats, but did not induce guinea pig gall bladder contraction. Therefore, we also compared the effects on the CCK-receptors in various regions of rat brain and the pancreatic acini using CCK-7 and CCK-8 analogues with a substituted glycine. The displacement curves and IC50 values of these analogues for [3H]CCK-8 specific binding are shown in Fig. 4 and Table 2 
Discussion
In this study, we compared the character istics of the CCK binding sites in the pancreas and various regions of the brain using[ 3H] CCK-8 as a ligand.
Scatchard analysis revealed the presence of high affinity binding sites for [3H]CCK-8 in the membranes from rat pancreatic acini and brain. The specific binding of [3H]CCK-8 in the pancreatic acini was saturable and reversible. In this tissue, the Kd value calculated by Scatchard an alysis was 0.76 nM, and was lower than the values in various regions of the brain. These Kd and Bma.X values of the CCK specific binding site were qualitatively similar to those reported by others (9, 18-22).
Innis and Snyder (8) and others (20, (23) (24) (25) (26) ) also re ported that the characteristics of the binding sites in the cerebral cortex are different from those of the pancreatic target sites with respect to the action of CCK as a gastro intestinal hormone. In this study, we analyzed the differences between the CCK receptors in the pancreatic acini and brain in more detail using well-designed synthetic CCK-8 an alogues.
The activity of CCK-8 for displacing [3H] CCK-8 specific binding in the pancreatic acini was greater than those of its analogues. 7. SucCCK-7 has a structure that corre sponds to the structure of the des-amino aspartyl group in the N-terminal part of CCK 8 (Table 1) . Yanaihara et al. (26) found that the degradation at the N-terminal amino acid of CCK-8 by aminopeptidase is inhib ited by protecting the N-terminal a-amino group with a succinyl group. Knight et al. (27) also reported that analogues of CCK-8 in which the Gly residue was replaced by D-Ala or D-Trp were not degraded by the mem brane-bound enzyme of rat cerebral cortical synaptosomes. However, analogues with or without an N-terminal succinyl group showed similar displacing potency for the cerebral cortical CCK receptor, indicating that the succinyl group had little influence on the potencies of these analogues for displacing 3H-CCK-8 specific binding in the cerebral cortex.
The C-terminals of CCK-4, CCK-5 and Suc[des Phe7]CCK-7 and about three orders less potent displacing activity than CCK-8 on the pancreatic CCK receptor. These results corresponded to the lack of PZ activity in these analogues (26). The low abilities of NS-CCK-8 and Suc[Phe(NHS03H)']CCK-7 to bind to the pancreatic CCK receptor also corresponded to the low PZ activities of these analogues. These results clearly indicate that the entire molecular structure of the CCK-7 or CCK-8 sequence, particularly, the Gly residue at position 3 or 4 in CCK-7 and CCK 8, is required for high affinity binding to the pancreatic acini. The Tyr residue connected to the -0S03H group and the carboxy terminal Phe residue were essential for binding to the pancreatic CCK receptor, and their positions were also very important for biological activity. Thus, the characteristics of these analogues for binding to the pancreatic acini were almost parallel to their phy siological activities; that is, CCK-8, SucCCK 7 and Suc[Sar3]CCK-7 strongly stimulated pancreatic exocrine secretion, whereas CCK 4, CCK-5 and Suc[des Phe7]CCK-7 did not (11, 26).
On the other hand, the binding activities of CCK-8, CCK-7, SucCCK-7 and Suc[Sar3] CCK-7 were similar and were strongest for the CCK receptors in the various regions of the brain. The binding affinity of Suc[des is required for recognition of the CCK receptor in the cerebral cortex. Rehfeld et al. (28, 29) re ported that CCK-4 peptide may play a role as a transmitter in the central nervous system. More recently, both CCK-8 and its C-terminal fragment CCK-4 were reported to bind to a single class of high affinity binding sites (30, 31) . Our finding that CCK-4 had relatively high ability to bind to the CCK receptor in the cerebral cortex is consistent with these re ports. The present results for CCK-4 in dis placement experiments also support our previous finding that intraperitoneal injection of CCK-4 as well as of CCK-8 suppressed locomotor hyperactivity induced by metham phetamine and TRH in mice (6) .
The present studies using CCK-8 an alogues clearly demonstrated differences in the recognition sites for CCK receptors in the pancreatic acini and brain of rats. These results suggest that the structure of the rat brain CCK receptor may be different from that of the rat pancreatic CCK receptor.
